{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:56:49Z","timestamp":1773899809736,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.rbmo.2012.02.027","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T00:02:43Z","timestamp":1360022563000},"page":"431-439","source":"Crossref","is-referenced-by-count":48,"title":["Can anti-M\u00fcllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?"],"prefix":"10.1016","volume":"26","author":[{"given":"R.","family":"Fleming","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Broekmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Calhaz-Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Dracea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nyboe Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Blockeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lunenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Platteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Smitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"de Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2012.02.027_b0005","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","author":"Al-Inany","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rbmo.2012.02.027_b0010","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","volume":"3","author":"Al-Inany","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rbmo.2012.02.027_b0015","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review","volume":"14","author":"Al-Inany","year":"2007","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.02.027_b0020","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1210\/endo.136.11.7588229","article-title":"Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth","volume":"136","author":"Baarends","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2012.02.027_b0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/jrf.0.0690343","article-title":"Factors regulating the growth of the preovulatory follicle in the sheep and human","volume":"69","author":"Baird","year":"1983","journal-title":"J. Reprod. Fertil."},{"key":"10.1016\/j.rbmo.2012.02.027_b0030","first-page":"40","article-title":"Extended analyses of the German IVF Registry (D\u00b7I\u00b7R): andrological aspects, medical-economical assumptions related to the shift from IVF to ICSI and stimulation with gonadotropins","volume":"7","author":"Bals-Pratsch","year":"2010","journal-title":"J. Reproduktionsmed. Endokrinol."},{"key":"10.1016\/j.rbmo.2012.02.027_b0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1749-6632.1991.tb37920.x","article-title":"Synergistic effect of growth hormone and gonadotropins in achieving conception in \u2018clonidine-negative\u2019 patients with unexplained infertility","volume":"626","author":"Blumenfeld","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.rbmo.2012.02.027_b0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.02.027_b0040","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2012.02.027_b0050","first-page":"29","article-title":"Six office tests to assess ovarian reserve, and what they tell you","volume":"20","author":"Butts","year":"2008","journal-title":"OGB Manage."},{"key":"10.1016\/j.rbmo.2012.02.027_b0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0092-8674(86)90783-X","article-title":"Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells","volume":"45","author":"Cate","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.rbmo.2012.02.027_b0060","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0015-0282(99)00639-1","article-title":"Serum mullerian-inhibiting substance levels during normal menstrual cycles","volume":"73","author":"Cook","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.02.027_b0065","first-page":"CD000099","article-title":"Growth hormone for in vitro fertilization","author":"Duffy","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rbmo.2012.02.027_b0070","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/molehr\/gaq001","article-title":"Concentrations of anti-Mullerian hormone in fluid from small human antral follicles show a negative correlation with CYP19 mRNA expression in the corresponding granulosa cells","volume":"16","author":"Eilso Nielsen","year":"2010","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1471-0528.1982.tb04642.x","article-title":"A new systematic treatment for infertile women with abnormal hormone profiles","volume":"89","author":"Fleming","year":"1982","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.rbmo.2012.02.027_b0080","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/humrep\/dei499","article-title":"Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone","volume":"21","author":"Fleming","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0260","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.rbmo.2010.05.018","article-title":"The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles","volume":"21","author":"Fleming","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.02.027_b0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0303-7207(94)90274-7","article-title":"Welcome to the family: the anti-mullerian hormone receptor","volume":"100","author":"Grootegoed","year":"1994","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.rbmo.2012.02.027_b0090","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2012.02.027_b0100","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/humrep\/dep246","article-title":"GnRHa to trigger final oocyte maturation: a time to reconsider","volume":"24","author":"Humaidan","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0095","doi-asserted-by":"crossref","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice?","author":"Humaidan","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2012.02.027_b0105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2012.02.027_b0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2010.08.011","article-title":"Development of a second generation anti-M\u00fcllerian hormone (AMH) ELISA","volume":"362","author":"Kumar","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.rbmo.2012.02.027_b0120","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/humrep\/deh508","article-title":"Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation","volume":"19","author":"La Marca","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0135","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2012.02.027_b0125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.rbmo.2010.11.005","article-title":"Anti-Mullerian hormone-based prediction model for a live birth in assisted reproduction","volume":"22","author":"La Marca","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.02.027_b0265","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.fertnstert.2012.07.186","article-title":"IVF\/ICSI patients predicted to be high responders by their AMH level may benefit from HP-hMG treatment","volume":"98","author":"La Marca","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.02.027_b0145","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/humrep\/dem033","article-title":"Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development","volume":"22","author":"Lainas","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2012.02.027_b0155","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1093\/humrep\/deq204","article-title":"Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction","volume":"25","author":"Lee","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0160","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10815-008-9266-6","article-title":"Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve","volume":"25","author":"Lekamge","year":"2008","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2012.02.027_b0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rbmo.2009.10.009","article-title":"Anti-Mullerian hormone testing is useful for individualization of stimulation protocols in oocyte donors","volume":"20","author":"Nakhuda","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.02.027_b0180","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0185","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.rbmo.2011.05.006","article-title":"External validation of nomogram for the decline in serum anti-Mullerian hormone in women: a population study of 15,834 infertility patients","volume":"23","author":"Nelson","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.02.027_b0270","doi-asserted-by":"crossref","first-page":"e731","DOI":"10.1016\/j.fertnstert.2010.08.022","article-title":"Nomogram for the decline in serum antimullerian hormone: a population study of 9601 infertility patients","volume":"95","author":"Nelson","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.02.027_b0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1472-6483(10)60256-8","article-title":"Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study","volume":"18","author":"Olivennes","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.02.027_b0195","first-page":"CD004379","article-title":"Interventions for \u2018poor responders\u2019 to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)","author":"Pandian","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rbmo.2012.02.027_b0200","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/REP-09-0415","article-title":"Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high?","volume":"139","author":"Pellatt","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.rbmo.2012.02.027_b0205","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/humrep\/deg472","article-title":"A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a \u2018standard\u2019 dose of 150 IU\/day in \u2018standard\u2019 patients undergoing IVF\/ICSI treatment","volume":"18","author":"Popovic-Todorovic","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0255","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/gme.0b013e3181f8d9e0","article-title":"Changes in serum antim\u00fcllerian hormone levels across the ovulatory menstrual cycle in late reproductive age","volume":"18","author":"Robertson","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.rbmo.2012.02.027_b0210","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.02.027_b0215","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.fertnstert.2009.07.1674","article-title":"Anti-Mullerian hormone and inhibin B variability during normal menstrual cycles","volume":"94","author":"Sowers","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.02.027_b0220","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0225","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/humupd\/8.2.141","article-title":"The variability of female reproductive ageing","volume":"8","author":"te Velde","year":"2002","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2012.02.027_b0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts","volume":"25","author":"van Disseldorp","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0235","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0240","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/humrep\/der134","article-title":"Live birth chances in women with extremely low-serum anti-Mullerian hormone levels","volume":"26","author":"Weghofer","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.02.027_b0245","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/humrep\/der182","article-title":"Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF","volume":"26","author":"Yates","year":"2011","journal-title":"Hum. Reprod."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264831300059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264831300059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T07:07:40Z","timestamp":1562656060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147264831300059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S147264831300059X"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2012.02.027","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}